Allison I Daniel, Kirrily de Polnay, Michael McCaul, Jaden Bendabenda, Zita Weise Prinzo, Celeste E Naude
{"title":"Development of core outcome sets for effectiveness trials focused on infants and children with wasting and nutritional oedema.","authors":"Allison I Daniel, Kirrily de Polnay, Michael McCaul, Jaden Bendabenda, Zita Weise Prinzo, Celeste E Naude","doi":"10.1136/bmjgh-2024-017225","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The 2023 WHO guideline on the prevention and management of wasting and nutritional oedema includes recommendations informed by best evidence from systematic reviews addressing critical and important outcomes. Multiple outcomes across trials were a challenge during guideline development, highlighting a need to establish core outcome sets (COS) for wasting and nutritional oedema. Informed by Core Outcome Measures in Effectiveness Trials (COMET) Initiative best practice methods, we aimed to develop six COS for effectiveness trials around prevention and management of wasting and nutritional oedema in infants and children.</p><p><strong>Methods: </strong>Guideline Development Group and UNICEF/WHO Technical Advisory Group on Wasting and Nutritional Oedema members were invited to participate in a Delphi process to establish these COS. This involved scoring outcomes in two rounds of a survey (Likert scale from 1 to 9), with consensus in the second round defined as a minimum of 70% of the expert panel giving a score of at least 7 and <15% scoring 3 or below.</p><p><strong>Results: </strong>Twenty-five of 36 invited participants completed each survey, followed by multiple consensus meetings to reach agreement on the outcomes. Through this Delphi process, we developed six COS for infants <6 months of age with wasting and/or nutritional oedema and/or underweight in (1) inpatient and (2) outpatient/community settings, infants and children 6-59 months of age with severe wasting and/or nutritional oedema in (3) inpatient and (4) outpatient/community settings, infants and children 6-59 months of age with moderate wasting in (5) outpatient/community settings and (6) prevention of wasting and nutritional oedema.</p><p><strong>Conclusion: </strong>Primary research, future guidelines and related decision-making stand to be strengthened by these six COS, including the most critical outcomes from a child health perspective to be evaluated in future effectiveness trials on wasting and nutritional oedema. Uptake of these COS will inform their further development.</p>","PeriodicalId":9137,"journal":{"name":"BMJ Global Health","volume":"10 Suppl 5","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12496088/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Global Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjgh-2024-017225","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The 2023 WHO guideline on the prevention and management of wasting and nutritional oedema includes recommendations informed by best evidence from systematic reviews addressing critical and important outcomes. Multiple outcomes across trials were a challenge during guideline development, highlighting a need to establish core outcome sets (COS) for wasting and nutritional oedema. Informed by Core Outcome Measures in Effectiveness Trials (COMET) Initiative best practice methods, we aimed to develop six COS for effectiveness trials around prevention and management of wasting and nutritional oedema in infants and children.
Methods: Guideline Development Group and UNICEF/WHO Technical Advisory Group on Wasting and Nutritional Oedema members were invited to participate in a Delphi process to establish these COS. This involved scoring outcomes in two rounds of a survey (Likert scale from 1 to 9), with consensus in the second round defined as a minimum of 70% of the expert panel giving a score of at least 7 and <15% scoring 3 or below.
Results: Twenty-five of 36 invited participants completed each survey, followed by multiple consensus meetings to reach agreement on the outcomes. Through this Delphi process, we developed six COS for infants <6 months of age with wasting and/or nutritional oedema and/or underweight in (1) inpatient and (2) outpatient/community settings, infants and children 6-59 months of age with severe wasting and/or nutritional oedema in (3) inpatient and (4) outpatient/community settings, infants and children 6-59 months of age with moderate wasting in (5) outpatient/community settings and (6) prevention of wasting and nutritional oedema.
Conclusion: Primary research, future guidelines and related decision-making stand to be strengthened by these six COS, including the most critical outcomes from a child health perspective to be evaluated in future effectiveness trials on wasting and nutritional oedema. Uptake of these COS will inform their further development.
期刊介绍：
BMJ Global Health is an online Open Access journal from BMJ that focuses on publishing high-quality peer-reviewed content pertinent to individuals engaged in global health, including policy makers, funders, researchers, clinicians, and frontline healthcare workers. The journal encompasses all facets of global health, with a special emphasis on submissions addressing underfunded areas such as non-communicable diseases (NCDs). It welcomes research across all study phases and designs, from study protocols to phase I trials to meta-analyses, including small or specialized studies. The journal also encourages opinionated discussions on controversial topics.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
